Table of Contents Author Guidelines Submit a Manuscript
Advances in Medicine
Volume 2016 (2016), Article ID 9131680, 4 pages
http://dx.doi.org/10.1155/2016/9131680
Clinical Study

Changes of Nitric Oxide and Peroxynitrite Serum Levels during Drug Therapy in Patients with Obsessive-Compulsive Disorder

1School of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
2Education Development Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
3Student Research Committee, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
4School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran

Received 22 April 2016; Revised 27 August 2016; Accepted 27 September 2016

Academic Editor: Gianfranco Spalletta

Copyright © 2016 Leila Kouti et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. V. Calabrese, D. Boyd-Kimball, G. Scapagnini, and D. A. Butterfield, “Nitric oxide and cellular stress response in brain aging and neurodegenerative disorders: the role of vitagenes,” In Vivo, vol. 18, no. 3, pp. 245–268, 2004. View at Google Scholar · View at Scopus
  2. L. Kouti, M. Noroozian, S. Akhondzadeh et al., “Nitric oxide and peroxynitrite serum levels in Parkinson's disease: correlastion of oxidative stress and the severity of the disease,” European Review for Medical and Pharmacological Sciences, vol. 17, no. 7, pp. 964–970, 2013. View at Google Scholar · View at Scopus
  3. R. Krolow, D. M. Arcego, C. Noschang, S. N. Weis, and C. Dalmaz, “Oxidative imbalance and anxiety disorders,” Current Neuropharmacology, vol. 12, no. 2, pp. 193–204, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Selek, H. Herken, M. Bulut et al., “Oxidative imbalance in obsessive compulsive disorder patients: a total evaluation of oxidant-antioxidant status,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 32, no. 2, pp. 487–491, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. G. Zai, E. J. Brandl, D. J. Müller, M. A. Richter, and J. L. Kennedy, “Pharmacogenetics of antidepressant treatment in obsessive-compulsive disorder: an update and implications for clinicians,” Pharmacogenomics, vol. 15, no. 8, pp. 1147–1157, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Krass, K. Rünkorg, G. Wegener, and V. Volke, “Nitric oxide is involved in the regulation of marble-burying behavior,” Neuroscience Letters, vol. 480, no. 1, pp. 55–58, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. S. N. Umathe, P. S. Bhutada, N. S. Jain, Y. R. Mundhada, S. S. Borkar, and B. Dhumal, “Role of nitric oxide in obsessive-compulsive behavior and its involvement in the anti-compulsive effect of paroxetine in mice,” Nitric Oxide—Biology and Chemistry, vol. 21, no. 2, pp. 140–147, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. V. Volke, G. Wegener, M. Bourin, and E. Vasar, “Antidepressant- and anxiolytic-like effects of selective neuronal NOS inhibitor 1-(2-trifluoromethylphenyl)-imidazole in mice,” Behavioural Brain Research, vol. 140, no. 1-2, pp. 141–147, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Atmaca, E. Tezcan, M. Kuloglu, and B. Ustundag, “Plasma nitrate values in patients with obsessive-compulsive disorder,” Psychiatry and Clinical Neurosciences, vol. 59, no. 5, pp. 621–623, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. D. Kalaycı, B. Dikmen, M. Kaçmaz, V. Taşpınar, D. Örnek, and Ö. Turan, “Plasma levels of interleukin-10 and nitric oxide in response to two different desflurane anesthesia flow rates,” Revista Brasileira de Anestesiologia, vol. 64, no. 4, pp. 292–298, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. T. L. Larsen, V. Nilsen, D. O. Andersen, G. Francis, P. Rustad, and M. A. Mansoor, “Comparison of high-pressure liquid chromatography (HPLC) and Griess reagent-spectroscopic methods for the measurement of nitrate in serum from healthy individuals in the Nordic countries,” Clinical Biochemistry, vol. 41, no. 18, pp. 1474–1481, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Sun, X. Zhang, M. Broderick, and H. Fein, “Measurement of nitric oxide production in biological systems by using griess reaction assay,” Sensors, vol. 3, no. 8, pp. 276–284, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. E. D. Yilmaz, M. F. Üstündağ, A. G. Gençer, Y. Kivrak, Ö. Ünal, and M. Bilci, “Levels of nitric oxide, asymmetric dimethyl arginine, symmetric dimethyl arginine,and L-arginine in patients with obsessive-compulsive disorder,” Turkish Journal of Medical Sciences, vol. 46, pp. 775–782, 2016. View at Publisher · View at Google Scholar
  14. H. Herken, A. Gurel, S. Selek et al., “Adenosine deaminase, nitric oxide, superoxide dismutase, and xanthine oxidase in patients with major depression: impact of antidepressant treatment,” Archives of Medical Research, vol. 38, no. 2, pp. 247–252, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Selek, H. A. Savas, H. S. Gergerlioglu, F. Bulbul, E. Uz, and M. Yumru, “The course of nitric oxide and superoxide dismutase during treatment of bipolar depressive episode,” Journal of Affective Disorders, vol. 107, no. 1–3, pp. 89–94, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. N. P. Rao, G. Venkatasubramanian, V. Ravi, S. Kalmady, A. Cherian, and J. R. Yc, “Plasma cytokine abnormalities in drug-naïve, comorbidity-free obsessive-compulsive disorder,” Psychiatry Research, vol. 229, no. 3, pp. 949–952, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. G. Minutolo, A. Petralia, S. Dipasquale, and E. Aguglia, “Nitric oxide in patients with schizophrenia: the relationship with the severity of illness and the antipsychotic treatment,” Expert Opinion on Pharmacotherapy, vol. 13, no. 14, pp. 1989–1997, 2012. View at Publisher · View at Google Scholar
  18. P. Pacher, J. S. Beckman, and L. Liaudet, “Nitric oxide and peroxynitrite in health and disease,” Physiological Reviews, vol. 87, no. 1, pp. 315–424, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. P. S. Garry, M. Ezra, M. J. Rowland, J. Westbrook, and K. T. S. Pattinson, “The role of the nitric oxide pathway in brain injury and its treatment—from bench to bedside,” Experimental Neurology, vol. 263, pp. 235–243, 2015. View at Publisher · View at Google Scholar · View at Scopus
  20. M. N. Hughes, “Relationships between nitric oxide, nitroxyl ion, nitrosonium cation and peroxynitrite,” Biochimica et Biophysica Acta—Bioenergetics, vol. 1411, no. 2-3, pp. 263–272, 1999. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Moylan, H. A. Eyre, M. Maes, B. T. Baune, F. N. Jacka, and M. Berk, “Exercising the worry away: how inflammation, oxidative and nitrogen stress mediates the beneficial effect of physical activity on anxiety disorder symptoms and behaviours,” Neuroscience and Biobehavioral Reviews, vol. 37, no. 4, pp. 573–584, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. E. Ozdemir, S. Cetinkaya, S. Ersan, S. Kucukosman, and E. E. Ersan, “Serum selenium and plasma malondialdehyde levels and antioxidant enzyme activities in patients with obsessive-compulsive disorder,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 33, no. 1, pp. 62–65, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Chakraborty, O. P. Singh, A. Dasgupta, N. Mandal, and H. N. Das, “Correlation between lipid peroxidation-induced TBARS level and disease severity in obsessive-compulsive disorder,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 33, no. 2, pp. 363–366, 2009. View at Publisher · View at Google Scholar · View at Scopus